SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-18-010386
Filing Date
2018-02-16
Accepted
2018-02-16 16:20:42
Documents
68
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a17-28738_110k.htm 10-K 1731243
2 EX-21.1 a17-28738_1ex21d1.htm EX-21.1 3836
3 EX-23.1 a17-28738_1ex23d1.htm EX-23.1 3666
4 EX-31.1 a17-28738_1ex31d1.htm EX-31.1 10847
5 EX-31.2 a17-28738_1ex31d2.htm EX-31.2 10954
6 EX-32.1 a17-28738_1ex32d1.htm EX-32.1 6196
13 GRAPHIC g287381bui001.gif GRAPHIC 25452
14 GRAPHIC g287381bki001.gif GRAPHIC 22906
15 GRAPHIC g287381bki002.gif GRAPHIC 24668
16 GRAPHIC g287381bki003.gif GRAPHIC 25730
17 GRAPHIC g287381bii001.gif GRAPHIC 41607
18 GRAPHIC g287381bii002.gif GRAPHIC 21265
19 GRAPHIC g287381bii003.gif GRAPHIC 21834
20 GRAPHIC g287381bii004.gif GRAPHIC 26134
  Complete submission text file 0001104659-18-010386.txt   5525417

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dova-20171231.xml EX-101.INS 833514
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dova-20171231.xsd EX-101.SCH 43956
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dova-20171231_cal.xml EX-101.CAL 34486
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT dova-20171231_lab.xml EX-101.LAB 381029
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dova-20171231_pre.xml EX-101.PRE 311822
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dova-20171231_def.xml EX-101.DEF 186144
Mailing Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713 919-806-4487
Dova Pharmaceuticals, Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38135 | Film No.: 18621456
SIC: 2834 Pharmaceutical Preparations